KPTI compared with OKUR: revenue, margins and what each company keeps, and the suppliers and customers both name

KPTIKaryopharm Therapeutics Inc.

Mkt capRevenueRevenue

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

KPTIKaryopharm Therapeutics Inc.

OKUROnKure Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KPTI1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±32.0%▼−1.97%×0.06

OKUR1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±80.0%▲+1.46%×0.02

= impliedKPTI realized, solidOKUR realized, hatchedOne scale, both sides: full bar = 80%× = |realized| ÷ impliedSource: market data

KPTIKaryopharm Therapeutics Inc.

0.11▼−83.81%· post 0.12

Mkt cap$15.0MRevenue$33MQ2 FY26Revenue$146MFY25

OKUROnKure Therapeutics, Inc.

2.60▼−0.58%· post 2.60

ClosedNov 2 '26

Mkt cap$104.9MRevenue—Revenue—

Compare

ClosedNov 2 '26

KPTIKaryopharm Therapeutics Inc.

OKUROnKure Therapeutics, Inc.

0.11▼−83.81%post 0.12

Price

2.60▼−0.58%post 2.60

$15.0M

Mkt cap

$104.9M

Q2 FY26$33M

Revenue

—

FY25$146M

Revenue

—

KPTI0.11▼−83.81%vsOKUR2.60▼−0.58%ClosedNov 2 '26